Abstract:BACKGROUND:Multidrug resistance is the main obstacle to the efficiency of systemic chemotherapy against hematologic malignancy. This study investigated the reversible effect of the copolymer wogonin and daunorubicin coloaded into Fe(3)O(4) magnetic nanoparticles, and the mechanism potentially involved.METHODS:The growth inhibition rate of K562/A02 cells was investigated by MTT assay, and apoptosis of cells and the intracellular daunorubicin concentration were detected by flow cytometry. Distribution of nanoparticles taken up by K562/A02 cells was observed under a transmission electron microscope and demonstrated by Prussian blue staining. The transcription level of MDR1 mRNA and expression of P-glycoprotein were determined by reverse transcriptase polymerase chain reaction and Western blotting assay, respectively.RESULTS:The reversible effect of daunorubicin-wogonin magnetic nanoparticles was 8.87-fold that of daunorubicin + wogonin and of daunorubicin magnetic nanoparticles. Transmission electron microscopy and Prussian blue staining revealed that the nanoparticles were located in the endosome vesicles of cytoplasm. Also, the apoptosis rate and accumulation of intracellular daunorubicin in the daunorubicin-wogonin magnetic nanoparticle group were significantly higher than that in the daunorubicin, daunorubicin + wogonin, and daunorubicin magnetic nanoparticle groups. Furthermore, transcription of MDR1 mRNA and expression of P-glycoprotein in K562/A02 cells were significantly downregulated in the daunorubicin-wogonin magnetic nanoparticle group compared with the other groups.CONCLUSION:These findings suggest that the remarkable effects of the novel daunorubicin-wogonin magnetic nanoparticle formulation on multidrug resistant K562/A02 leukemia cells would be a promising strategy for overcoming multidrug resistance.

Synergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cells.

Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells.

The Application of Fe3o4 Nanoparticles in Cancer Research: A New Strategy to Inhibit Drug Resistance

Magnetic Nanoparticle Of Fe3o4 And 5-Bromotetrandrin Interact Synergistically To Induce Apoptosis By Daunorubicin In Leukemia Cells

Synergistic effect of magnetic nanopartical Fe_3O_4,Au and daunomycin on K562/A02

Enhancement effect of nano Fe3O4 to the drug accumulation of doxorubicin in cancer cells

Reversal in Multidrug Resistance by Magnetic Nanoparticle of Fe3o4 Loaded with Adriamycin and Tetrandrine in K562/A02 Leukemic Cells

The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells.

Effect of Magnetic Nanoparticles of Fe3O4 and Wogonin on the Reversal of Multidrug Resistance in K562/A02 Cell Line.

Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.

Doxorubicin-CdS Nanoparticles: A Potential Anticancer Agent for Enhancing the Drug Uptake of Cancer Cells

Effect of Surface Chemistry Modification of Functional Gold Nanoparticles on the Drug Accumulation of Cancer Cells

Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo.

Magnetic Nanoparticle of Fe3O4 Loaded with Daunorubicin Reverse Leukemia Multidrug Resistance in Vivo

In vitro study of drug accumulation in cancer cells via specific association with CdS nanoparticles.

Novel Nanocomposite Of Nano Fe3o4 And Polylactide Nanofibers For Application In Drug Uptake And Induction Of Cell Death Of Leukemia Cancer Cells

Multifunctional Magnetic Nanoparticles for Synergistic Enhancement of Cancer Treatment by Combinatorial Radio Frequency Thermolysis and Drug Delivery

Towards Magnetic-Enhanced Cellular Uptake, MRI and Chemotherapeutics Delivery by Magnetic Mesoporous Silica Nanoparticles

Fe3O4 nanoparticles with daunorubicin induce apoptosis through caspase 8-PARP pathway and inhibit K562 leukemia cell-induced tumor growth in vivo.

A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy.

Magnetic Fe3O4 Nanoparticles and Chemotherapy Agents Interact Synergistically to Induce Apoptosis in Lymphoma Cells